Fundz

Evergreen Theragnostics reported raising $15.5 Million in an initial SEC Form D filing, from an offering of $15.5 Million

RECENTLY ACQUIREDAug 18, 2023Late filing, first sale Dec 15, 2022

Amount Raised

$15.5 Million

$15.5 Million sold, per SEC Form D (first sale Dec 15, 2022)

Round Type

Venture

SummitManufacturingBiotechnologyHealth CareMedical Device

Who else raised in Medical Device and Manufacturing around the same time

Companies in the same sectors as Evergreen Theragnostics that raised within 45 days of this round, from Fundz verified event records.

  • MedX Health raised an undisclosed amount (Convertible Note) on January 6, 2023.
  • CARMAT raised an undisclosed amount (Funding Round) on December 19, 2022.
  • MedX Health raised an undisclosed amount (Convertible Note) on November 18, 2022.
  • The Shape Sensing Company raised an undisclosed amount (Funding Round) on November 10, 2022.
  • Biocoat raised an undisclosed amount on November 2, 2022.
  • Nusano raised $10M on November 1, 2022.

Who to call at Evergreen Theragnostics, and when

A new round usually means Evergreen Theragnostics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Evergreen Theragnostics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Evergreen Theragnostics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Evergreen Theragnostics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Evergreen Theragnostics

Location

Summit, Ohio, United States

About

Evergreen Theragnostics is focused on improving the available options for cancer patients using radiopharmaceuticals. The company is engaged in three core areas: CDMO, Products, and Drug Discovery. Evergreen is headquartered in Springfield, NJ in a state-of-the-art GMP radiopharmaceutical facility. The company was founded in 2019 by a team that brings a strong track record in theragnostic radiopharmaceutical manufacturing and commercialization. For more information, please visit www.evergreentgn.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Evergreen Theragnostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Evergreen Theragnostics's next move

See what Strategic adds

Evergreen Theragnostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.